Melbourne
Australia
Peter MacCallum Cancer Centre - Department of Haematology
Neuroendocrine neoplasia, Peptide receptor radionuclide/chemoradionuclide therapy, Therapy-related myeloid neoplasms, 177Lu-DOTA-octreotate